GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹61.15 | ₹54.76 | ₹34.83 | ₹36.05 | ₹100.04 |
What is the latest Earnings Per Share (EPS) of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹61.15 |
| Mar2025 | ₹54.76 |
| Mar2024 | ₹34.83 |
| Mar2023 | ₹36.05 |
| Mar2022 | ₹100.04 |
How is Earnings Per Share (EPS) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹61.15 | 11.67 | |
| Mar2025 | ₹54.76 | 57.22 | |
| Mar2024 | ₹34.83 | -3.38 | |
| Mar2023 | ₹36.05 | -63.96 | |
| Mar2022 | ₹100.04 | - | |
Compare Earnings Per Share (EPS) of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹48,841.4 Cr | 10.1% | 16% | 0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 10.1% |
16% |
0.4% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses